Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -6 of 6 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 3/28/2007 First Published: 10/1/2002


1.		Phase IV Randomized Study of Epoetin beta for Anemia Management in Patients With Stage IIB, III, or IVA Cervical Cancer Treated With Cisplatin and Radiotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Supportive care, Treatment				Completed				Over 18				Pharmaceutical / Industry				AGOSG-OVAR-MO16375-MARCH EU-20217, ROCHE-MO16375, ROCHE-RO2053859, NCT00046969


2.		A Study of the Management of Blood Loss in Patients Undergoing Surgical Removal of Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Supportive care, Treatment				Completed				18 and over				Pharmaceutical / Industry				CR003460 NCT00264095


3.		Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Closed				20 to 79				Pharmaceutical / Industry				EPO316 JP NCT00628043


4.		Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate or Advanced Hodgkins Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				61 to 75				Other				BACOPP-21 NCT00284271

Last Modified: 10/22/2008 First Published: 11/14/2007


5.		Phase II Study of Epoetin beta for Fatigue and Anemia in Patients Receiving Palliative Care for Malignant Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Closed				18 and over				Other				CHUL-NEOPALIA RECF0359, NEOPALIA, NCT00559195


6.		A Study of NeoRecormon (Epoetin Beta), CellCept (Mycophenolate Mofetil) and Prednisone in Patients With Low or Intermediate Myelodysplastic Syndromes.

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				ML20559 NCT00551291

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute